Axsome Therapeutics (MEX:AZSM) Short-Term Debt: MXN1,221 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AZSM Axsome Therapeutics Inc MEX:AZSM
30 GF Score
Price MXN1,519.00
! 1 Warning Sign
View Full Analysis

What is Axsome Therapeutics Short-Term Debt?

Axsome Therapeutics MEX:AZSM 30 Short-Term Debt is MXN1,221 Mil as of Jun. 2026. GuruFocus rates MEX:AZSM with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Axsome Therapeutics's Short-Term Debt for the quarter that ended in Jun. 2026 was MXN1,221 Mil.

Axsome Therapeutics's quarterly Short-Term Debt increased from Dec. 2025 (MXN1,260 Mil) to Mar. 2026 (MXN1,262 Mil) but then declined from Mar. 2026 (MXN1,262 Mil) to Jun. 2026 (MXN1,221 Mil).

Axsome Therapeutics's annual Short-Term Debt stayed the same from Dec. 2023 (MXN0 Mil) to Dec. 2024 (MXN0 Mil) but then increased from Dec. 2024 (MXN0 Mil) to Dec. 2025 (MXN1,260 Mil).

Axsome Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Axsome Therapeutics Short-Term Debt Related Terms

Axsome Therapeutics Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Axsome Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axsome Therapeutics Short-Term Debt Chart

Axsome Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1,260.40

Axsome Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,318.04 1,284.09 1,260.40 1,262.29 1,221.43
MEX:AZSM
30GF Score
Axsome Therapeutics Inc MEX:AZSM
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of MXN1,221 Mil mean?
Axsome Therapeutics (MEX:AZSM) has a Short-Term Debt of MXN1,221 Mil as of Jun. 2026.
Is Axsome Therapeutics' Short-Term Debt too high?
Axsome Therapeutics' current Short-Term Debt is MXN1,221 Mil. Overall, Axsome Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Axsome Therapeutics' Short-Term Debt compare to MDGL and ARWR?
Axsome Therapeutics' Short-Term Debt of MXN1,221 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Axsome Therapeutics's current Short-Term Debt is MXN1,221 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axsome Therapeutics stock overvalued right now?
Axsome Therapeutics (MEX:AZSM) has a current Short-Term Debt of MXN1,221 Mil. The current Short-Term Debt is MXN1,221 Mil. Axsome Therapeutics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Axsome Therapeutics (MEX:AZSM), the current Short-Term Debt is MXN1,221 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Axsome Therapeutics Business Description

Address One World Trade Center, 29th Floor, New York, NY, USA, 10007
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
30GF Score

Get the complete analysis for MEX:AZSM

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,519.00
Price